MANNKIND CORP Paid-in-Kind Interest
MANNKIND CORP (MNKD) reported Paid-in-Kind Interest of $4.48 million for the 12-month period ending 2016-12-31, per its 10-K filed 2019-02-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2019-02-26
- MANNKIND CORP paid-in-kind interest for the quarter ending 2016-12-31 was $353.00K, a 58.67% decline year-over-year.
- MANNKIND CORP paid-in-kind interest for the quarter ending 2016-09-30 was $1.52M, a 185.37% increase year-over-year.
- MANNKIND CORP paid-in-kind interest for the quarter ending 2016-06-30 was $1.44M, a 518.97% increase year-over-year.
- MANNKIND CORP paid-in-kind interest for the quarter ending 2016-03-31 was $1.17M, a 3439.39% increase year-over-year.
- MANNKIND CORP paid-in-kind interest for fiscal 2016 was $4.48M, a 171.07% increase from fiscal 2015.
- MANNKIND CORP paid-in-kind interest for fiscal 2015 was $1.65M.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 12 month |
|---|---|---|---|---|
| 2016-12-31 | $353.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $1.87M derived: sum of 2 quarters · filed 2019-02-26 | $3.31M derived: sum of 3 quarters · filed 2019-02-26 | $4.48M 10-K · filed 2019-02-26 |
| 2016-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.96M derived: sum of 2 quarters · filed 2017-11-07 | $4.13M 10-Q · filed 2017-11-07 | $4.98M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $1.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $2.60M 10-Q · filed 2017-08-07 | $3.46M derived: sum of 3 quarters · filed 2018-02-27 | $3.99M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $1.17M 10-Q · filed 2017-05-10 | $2.02M derived: sum of 2 quarters · filed 2018-02-27 | $2.56M derived: sum of 3 quarters · filed 2018-02-27 | $2.79M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $854.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.39M derived: sum of 2 quarters · filed 2018-02-27 | $1.62M derived: sum of 3 quarters · filed 2018-02-27 | $1.65M 10-K · filed 2018-02-27 |
| 2015-09-30 | $533.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-09 | $765.00K derived: sum of 2 quarters · filed 2016-11-09 | $798.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $232.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2016-08-10 | $265.00K 10-Q/A · filed 2016-08-10 | ||
| 2015-03-31 | $33.00K 10-Q · filed 2016-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |